U.S. stocks closed at highs after encouraging domestic data alleviated concerns over continued signs of slowing growth in Europe and China.» Read More
Scientists advising the Food and Drug Administration said anemia drugs sold by Amgen and Johnson & Johnson should be allowed to stay on the market for chemotherapy patients.
Stocks closed higher Thursday after Standard & Poor's delivered the words Wall Street was waiting to hear: The end is in sight.
Amgen, the world's biggest biotech company in terms of sales (Genentech dwarfs Amgen in market cap: $86 billion vs. $51 billion) and Dow component Johnson & Johnson avoided a worst-case scenario this afternoon.
Ahead of the big FDA Advisory Committee meeting tomorrow, Amgen held a quick conference call with some reporters this afternoon. The outside panel of experts will be deciding whether to recommend putting more restrictions on the use of the blockbuster drugs used to fight anemia in cancer patients getting chemo. For Johnson and Johnson and especially Amgen, the stakes are high.
Shares of biotech giant Amgen fell as low as $43.14 (a new bottom) this morning after the briefing documents for Thursday's Food and Drug Administration Advisory Committee meeting were posted on the agency's website.
This is a big week for the world's top-two biotechnology companies and their investors. What’s going on and how can you trade it?
Billionaire Alfred Mann must not have liked watching stock in the company bearing his name fall to another new low today in the wake of Eli Lilly giving up on inhaled insulin.
This is a big week for the world's top-two biotechnology companies and their investors. Amgen goes before an FDA Advisory Committee Thursday about the side effects of its bread-and-butter franchise Aranesp.
Forbes just released its annual list of the world's wealthiest individuals, with Warren Buffett climbing to the number one spot. Here is the list of largest companies by Market Cap on the S&P 500.
With Warren Buffett nosing around Big Pharma, investors are starting to wonder if drug makers might be the remedy to what ails this market.
On the eve of the make-or-break Texas-Ohio primaries for Sen. Hillary Clinton, she remains in first place in at least one "poll." The Center for Responsive Politics has updated its list of top pharmaceuticals/health products-industry money recipients based on the most recent campaign finance reports and the former First Lady edges out Sen. Barack Obama...
What's the trade as a new breed of retirees begin their Miami migration?
Stocks are tumbling. Bonds yields are falling faster than Hillary Clinton's poll numbers. And fears are growing that the commodities bubble could burst. What to do?
The economy's worsening. So's inflation. And the stock market is tanking. What to do? CNBC asked market experts for their best investment advice. Here are some of their picks.
There's nearly $3.5 trillion dollars waiting to be invested in the markets, according to Frederic Dickson, chief market strategist of D.A. Davidson. So what's keeping it out? And what should investors do in the meantime?
Harbor Advisory's chief investment officer Jack DeGan has no doubts that these are challenging times. He's got some tough stocks to ride out the rough weather with.
As the democratic presidential candidates prepare to square off on health care issues at tonight's debate in Ohio, a new federal study points to accelerating growth in government spending on Medicare over the next ten years, as baby boomers become eligible for the healthcare entitlement program.
Q: On Fast Money’s trader radar we look at the stock that was lighting up screens across Wall Street. Founded in 1887 in a former wallpaper factory, this company was the first maker of ready to use anti-bacterial surgical dressings. Now the maker of Tylenol, it is the world’s largest health products company. But this company doesn't just cure headaches, a medical journal announced Friday that the company’s Remicade drug is proving effective in the treatment of Crohn’s disease Who is it?
According to The Center for Responsive Politics' web site Pfizer Chairman and CEO Jeff Kindler has opened his wallet again for Sen. Hillary Clinton. You can see his latest "give" here. Twice now within the past year Kindler has given the maximum amount ($2,300) an individual can contribute to a candidate.
How much coffee can one woman drink? Watch me. I never drank coffee until I started covering the O.J. Simpson trial (come to think of it, I never drank much alcohol before then, either).